Stephen Rohan
Overview
Explore the profile of Stephen Rohan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
253
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodrigues J, Rooms B, Hyde K, Rohan S, Nightingale A, Paton J, et al.
Int J Cardiovasc Imaging
. 2021 Feb;
37(6):1987-1997.
PMID: 33616783
Left ventricular ejection fraction (LVEF) has a limited role in predicting outlook in heart diseases including heart failure. We quantified the independent geometric factors that determine LVEF using cardiac MRI...
2.
Catic A, Kurtovic-Kozaric A, Sophian A, Mazur L, Skenderi F, Hes O, et al.
BMC Med Genet
. 2020 Oct;
21(1):202.
PMID: 33046021
Background: Metanephric adenoma (MA) is a rare benign renal neoplasm. On occasion, MA can be difficult to differentiate from renal malignancies such as papillary renal cell carcinoma in adults and...
3.
Rodrigues J, Rohan S, Dastidar A, Trickey A, Szantho G, Ratcliffe L, et al.
J Clin Hypertens (Greenwich)
. 2017 Feb;
19(3):335-336.
PMID: 28139052
No abstract available.
4.
Rodrigues J, Rohan S, Dastidar A, Harries I, Lawton C, Ratcliffe L, et al.
Eur Radiol
. 2016 Jul;
27(3):1125-1135.
PMID: 27368925
Objectives: European guidelines state left ventricular (LV) end-diastolic wall thickness (EDWT) ≥15mm suggests hypertrophic cardiomyopathy (HCM), but distinguishing from hypertensive heart disease (HHD) is challenging. We identify cardiovascular magnetic resonance...
5.
Rodrigues J, Rohan S, Dastidar A, Trickey A, Szantho G, Ratcliffe L, et al.
J Clin Hypertens (Greenwich)
. 2016 Jun;
18(11):1119-1127.
PMID: 27316563
Hypertensive heart disease is often associated with a preserved left ventricular ejection fraction despite impaired myocardial shortening. The authors investigated this paradox in 55 hypertensive patients (52±13 years, 58% male)...
6.
Bondarenko G, Ugolkov A, Rohan S, Kulesza P, Dubrovskyi O, Gursel D, et al.
Neoplasia
. 2015 Oct;
17(9):735-741.
PMID: 26476081
Patient-derived xenograft (PDX) tumor models have emerged as a new approach to evaluate the effects of cancer drugs on patients' personalized tumor grafts enabling to select the best treatment for...
7.
Rodrigues J, Dastidar A, Rohan S, MacIver D
Heart
. 2014 Oct;
101(1):83-4.
PMID: 25351508
No abstract available.
8.
Zhong M, Weisman P, Zhu B, Brassesco M, Yang Y, Linehan W, et al.
Diagn Mol Pathol
. 2013 May;
22(2):107-11.
PMID: 23628822
Xp11.2 translocation renal cell carcinoma (Xp11.2 RCC) is a subtype of RCC characterized by translocations involving a breakpoint at the TFE3 gene (Xp11.2). Moderate to strong nuclear TFE3 immunoreactivity has...
9.
Davion S, Rohan S, Nayar R, Kulesza P
Diagn Cytopathol
. 2011 Apr;
40(9):826-9.
PMID: 21472872
The majority of chromophobe renal cell carcinomas (CHRCC) are not aggressive, however, a subset are. The potential for metastasis makes recognition of CHRCC cells in cytologic preparations important for patient...
10.
Fox J, Rohan S, Pandit-Taskar N
Clin Nucl Med
. 2009 Apr;
34(5):294-5.
PMID: 19387207
No abstract available.